CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 145 enrolled
Drug / intervention
Flow Re-Direction Endoluminal Device (FRED)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01801007
NCT01801007N/ACompleted
CompareCT.gov

Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms

Microvention-Terumo, Inc.·interventional·Posted Feb 28, 2013·Updated Mar 8, 2021

In Brief

A clinical study evaluating Flow Re-Direction Endoluminal Device (FRED) for Intracranial Aneurysms. Completed, enrolled 145 participants across 24 sites in 2 countries.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of the MicroVention Flow Redirection Intraluminal Device (FRED) system when used in the treatment of wide-necked intracranial aneurysms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Aneurysms
CountriesJapan, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 28, 2013
Enrollment StartJul 1, 2013
Primary CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 13.3 years ago

Interventions

Flow Re-Direction Endoluminal Device (FRED)device